Prophase Labs Inc Financials
This page shows Prophase Labs Inc (PRPH) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores
Prophase Labs Inc has an operating margin of -570.6%, meaning the company retains $-571 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is down from -60.7% the prior year.
Prophase Labs Inc's revenue declined 80.6% year-over-year, from $35.0M to $6.8M. This contraction results in a growth score of 0/100.
Prophase Labs Inc has elevated debt relative to equity (D/E of 7.60), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.
Prophase Labs Inc's current ratio of 0.95 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 18/100, which could limit financial flexibility.
While Prophase Labs Inc generated -$17.5M in operating cash flow, capex of $906K consumed most of it, leaving -$18.4M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.
Prophase Labs Inc passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Prophase Labs Inc generates $0.33 in operating cash flow (-$17.5M OCF vs -$53.4M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Prophase Labs Inc earns $-11.5 in operating income for every $1 of interest expense (-$38.6M vs $3.4M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Prophase Labs Inc generated $6.8M in revenue in fiscal year 2024. This represents a decrease of 80.6% from the prior year.
Prophase Labs Inc's EBITDA was -$32.4M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 113.9% from the prior year.
Prophase Labs Inc generated -$18.4M in free cash flow in fiscal year 2024, representing cash available after capex. This represents a decrease of 32.0% from the prior year.
Prophase Labs Inc reported -$53.4M in net income in fiscal year 2024. This represents a decrease of 218.0% from the prior year.
Prophase Labs Inc earned $-2.61 per diluted share (EPS) in fiscal year 2024. This represents a decrease of 166.3% from the prior year.
Prophase Labs Inc held $678K in cash against $0 in long-term debt as of fiscal year 2024.
Prophase Labs Inc had 30M shares outstanding in fiscal year 2024. This represents an increase of 65.6% from the prior year.
Prophase Labs Inc's gross margin was -2.2% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is down 46.7 percentage points from the prior year.
Prophase Labs Inc's operating margin was -570.6% in fiscal year 2024, reflecting core business profitability. This is down 509.9 percentage points from the prior year.
Prophase Labs Inc's net profit margin was -788.2% in fiscal year 2024, showing the share of revenue converted to profit. This is down 740.3 percentage points from the prior year.
Prophase Labs Inc invested $594K in research and development in fiscal year 2024. This represents a decrease of 57.6% from the prior year.
Prophase Labs Inc spent $0 on share buybacks in fiscal year 2024, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 100.0% from the prior year.
Prophase Labs Inc invested $906K in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 56.5% from the prior year.
PRPH Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'23 | Q3'24 | Q2'24 | Q1'24 | Q4'22 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $883K-29.2% | $1.2M-12.9% | $1.4M | N/A | $8.4M-36.7% | $13.2M-31.5% | $19.3M-11.6% | $21.8M |
| Cost of Revenue | $1.0M+96.1% | $513K-43.3% | $905K | N/A | $6.0M-10.8% | $6.8M-22.9% | $8.8M-16.7% | $10.5M |
| Gross Profit | -$123K-116.8% | $734K+39.5% | $526K | N/A | $2.3M-63.9% | $6.4M-38.7% | $10.5M-6.8% | $11.3M |
| R&D Expenses | $6K+50.0% | $4K-95.9% | $97K | N/A | $428K-25.2% | $572K+297.2% | $144K-69.9% | $479K |
| SG&A Expenses | $4.6M+0.2% | $4.6M+13.0% | $4.1M | N/A | $8.2M-17.0% | $9.9M+19.8% | $8.3M-34.9% | $12.7M |
| Operating Income | -$4.8M-22.3% | -$3.9M-6.3% | -$3.7M | N/A | -$6.5M-39.1% | -$4.7M-632.3% | $875K+117.2% | -$5.1M |
| Interest Expense | $1.5M+163.9% | $587K+8.9% | $539K | N/A | $275K-5.5% | $291K+35.3% | $215K+66.7% | $129K |
| Income Tax | -$157K-120.2% | $779K | $0 | N/A | -$1.6M-11.5% | -$1.5M-10628.6% | $14K+100.5% | -$2.7M |
| Net Income | -$6.8M-52.9% | -$4.5M-212.8% | $4.0M | N/A | -$5.1M-49.4% | -$3.4M-725.5% | $550K+122.5% | -$2.4M |
| EPS (Diluted) | $-0.16-45.5% | $-0.11-200.0% | $0.11 | N/A | $-0.30-50.0% | $-0.20-766.7% | $0.03+125.0% | $-0.12 |
PRPH Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'23 | Q3'24 | Q2'24 | Q1'24 | Q4'22 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $65.7M+56.3% | $42.0M-16.1% | $50.1M-45.5% | $91.9M+0.2% | $91.7M+0.7% | $91.1M-4.5% | $95.4M+8.8% | $87.6M |
| Current Assets | $7.8M-68.4% | $24.6M-0.8% | $24.8M-47.9% | $47.6M-4.4% | $49.8M-9.4% | $55.0M-10.3% | $61.3M+0.7% | $60.8M |
| Cash & Equivalents | $405K+139.6% | $169K+92.0% | $88K-94.5% | $1.6M+129.2% | $702K-81.6% | $3.8M-60.2% | $9.6M+5.5% | $9.1M |
| Inventory | $266K-68.0% | $830K-27.5% | $1.1M-50.0% | $2.3M-54.7% | $5.1M+39.5% | $3.6M-16.0% | $4.3M+8.4% | $4.0M |
| Accounts Receivable | $3.3M-83.7% | $20.1M-0.6% | $20.2M-43.6% | $35.8M-7.3% | $38.6M+0.2% | $38.6M+1.9% | $37.8M+2.1% | $37.1M |
| Goodwill | $4.0M-24.1% | $5.2M0.0% | $5.2M0.0% | $5.2M0.0% | $5.2M0.0% | $5.2M0.0% | $5.2M-8.4% | $5.7M |
| Total Liabilities | $58.8M+92.3% | $30.6M-12.5% | $35.0M-17.7% | $42.5M+20.6% | $35.3M+10.9% | $31.8M-10.3% | $35.4M+47.5% | $24.0M |
| Current Liabilities | $55.3M+115.7% | $25.6M+6.5% | $24.1M+15.3% | $20.9M+27.1% | $16.4M+20.0% | $13.7M-25.9% | $18.5M+14.9% | $16.1M |
| Long-Term Debt | N/A | N/A | N/A | $2.9M | N/A | N/A | N/A | $0 |
| Total Equity | $6.9M-40.0% | $11.4M-24.4% | $15.1M-69.4% | $49.4M-12.5% | $56.4M-4.8% | $59.3M-1.1% | $59.9M-5.8% | $63.6M |
| Retained Earnings | -$65.7M-11.6% | -$58.9M-8.2% | -$54.4M-982.3% | -$5.0M-235.1% | $3.7M-58.0% | $8.9M-28.0% | $12.3M+4.7% | $11.8M |
PRPH Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'23 | Q3'24 | Q2'24 | Q1'24 | Q4'22 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$3.5M-1311.3% | -$247K+92.7% | -$3.4M-349.0% | -$753K+83.8% | -$4.7M+33.1% | -$7.0M-1561.6% | $476K-41.3% | $811K |
| Capital Expenditures | $0 | $0 | $0-100.0% | $239K-64.2% | $668K+1.2% | $660K+27.7% | $517K-67.6% | $1.6M |
| Free Cash Flow | -$3.5M-1311.3% | -$247K+92.7% | -$3.4M-240.8% | -$992K+81.4% | -$5.3M+30.1% | -$7.6M-18478.0% | -$41K+94.8% | -$785K |
| Investing Cash Flow | $0-100.0% | $67K-92.1% | $853K+167.5% | -$1.3M-480.7% | $332K-72.7% | $1.2M+173.5% | -$1.7M+67.0% | -$5.0M |
| Financing Cash Flow | $3.7M+1326.1% | $261K-86.5% | $1.9M-33.7% | $2.9M+143.7% | $1.2M+2653.2% | -$47K-102.8% | $1.7M+117.7% | -$9.5M |
| Dividends Paid | N/A | N/A | N/A | $0 | $0 | $0 | $0-100.0% | $2K |
| Share Buybacks | $0 | $0 | $0 | $0 | $0-100.0% | $47K-91.3% | $541K-43.2% | $952K |
PRPH Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'23 | Q3'24 | Q2'24 | Q1'24 | Q4'22 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | -13.9%-72.8pp | 58.9%+22.1pp | 36.8% | N/A | 27.8%-21.0pp | 48.8%-5.7pp | 54.5%+2.9pp | 51.6% |
| Operating Margin | -539.5%-227.3pp | -312.3%-56.3pp | -256.0% | N/A | -77.4%-42.2pp | -35.2%-39.8pp | 4.5%+27.8pp | -23.3% |
| Net Margin | -774.5%-415.9pp | -358.6%-635.8pp | 277.2% | N/A | -61.5%-35.4pp | -26.0%-28.9pp | 2.9%+14.0pp | -11.2% |
| Return on Equity | N/A | N/A | 26.2% | N/A | N/A | N/A | 0.9% | N/A |
| Return on Assets | -10.4%+0.2pp | -10.6%-18.6pp | 7.9% | N/A | -5.6%-1.8pp | -3.8%-4.4pp | 0.6%+3.4pp | -2.8% |
| Current Ratio | 0.14-0.8 | 0.96-0.1 | 1.03-1.3 | 2.28-0.8 | 3.04-1.0 | 4.02+0.7 | 3.32-0.5 | 3.78 |
| Debt-to-Equity | 8.58+5.9 | 2.68+0.4 | 2.31+2.3 | 0.06-0.6 | 0.63+0.1 | 0.54-0.1 | 0.59+0.6 | 0.00 |
| FCF Margin | -394.8%-375.0pp | -19.8%+216.5pp | -236.3% | N/A | -63.6%-6.0pp | -57.6%-57.4pp | -0.2%+3.4pp | -3.6% |
Note: The current ratio is below 1.0 (0.95), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is Prophase Labs Inc's annual revenue?
Prophase Labs Inc (PRPH) reported $6.8M in total revenue for fiscal year 2024. This represents a -80.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Prophase Labs Inc's revenue growing?
Prophase Labs Inc (PRPH) revenue declined by 80.6% year-over-year, from $35.0M to $6.8M in fiscal year 2024.
Is Prophase Labs Inc profitable?
No, Prophase Labs Inc (PRPH) reported a net income of -$53.4M in fiscal year 2024, with a net profit margin of -788.2%.
What is Prophase Labs Inc's earnings per share (EPS)?
Prophase Labs Inc (PRPH) reported diluted earnings per share of $-2.61 for fiscal year 2024. This represents a -166.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Prophase Labs Inc's EBITDA?
Prophase Labs Inc (PRPH) had EBITDA of -$32.4M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
What is Prophase Labs Inc's gross margin?
Prophase Labs Inc (PRPH) had a gross margin of -2.2% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.
What is Prophase Labs Inc's operating margin?
Prophase Labs Inc (PRPH) had an operating margin of -570.6% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is Prophase Labs Inc's net profit margin?
Prophase Labs Inc (PRPH) had a net profit margin of -788.2% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
What is Prophase Labs Inc's free cash flow?
Prophase Labs Inc (PRPH) generated -$18.4M in free cash flow during fiscal year 2024. This represents a -32.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Prophase Labs Inc's operating cash flow?
Prophase Labs Inc (PRPH) generated -$17.5M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Prophase Labs Inc's total assets?
Prophase Labs Inc (PRPH) had $63.2M in total assets as of fiscal year 2024, including both current and long-term assets.
What are Prophase Labs Inc's capital expenditures?
Prophase Labs Inc (PRPH) invested $906K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.
How much does Prophase Labs Inc spend on research and development?
Prophase Labs Inc (PRPH) invested $594K in research and development during fiscal year 2024.
How many shares does Prophase Labs Inc have outstanding?
Prophase Labs Inc (PRPH) had 30M shares outstanding as of fiscal year 2024.
What is Prophase Labs Inc's current ratio?
Prophase Labs Inc (PRPH) had a current ratio of 0.95 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.
What is Prophase Labs Inc's debt-to-equity ratio?
Prophase Labs Inc (PRPH) had a debt-to-equity ratio of 7.60 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Prophase Labs Inc's return on assets (ROA)?
Prophase Labs Inc (PRPH) had a return on assets of -84.4% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Prophase Labs Inc's cash runway?
Based on fiscal year 2024 data, Prophase Labs Inc (PRPH) had $678K in cash against an annual operating cash burn of $17.5M. This gives an estimated cash runway of approximately 0 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Prophase Labs Inc's Piotroski F-Score?
Prophase Labs Inc (PRPH) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Prophase Labs Inc's earnings high quality?
Prophase Labs Inc (PRPH) has an earnings quality ratio of 0.33x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Prophase Labs Inc cover its interest payments?
Prophase Labs Inc (PRPH) has an interest coverage ratio of -11.5x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Prophase Labs Inc?
Prophase Labs Inc (PRPH) scores 4 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.